Genetic biomarkers could personalise therapy for TNBC
Drug Discovery World
AUGUST 16, 2023
For example, women whose primary tumours have a higher presence of immune cell genes, and genes linked to their activity, are more likely to respond to docetaxel than carboplatin. Although immune features remained relatively stable, RNA-based features related to DNA damage repair pathways changed significantly.
52 
Let's personalize your content